Propensity-matched Analysis of Open Versus Robotic Primary Retroperitoneal Lymph Node Dissection for Clinical Stage II Testicular Cancer

医学 腹膜后淋巴结清扫术 睾丸癌 外科 围手术期 四分位间距 倾向得分匹配 置信区间 内科学 化疗
作者
Julián Chavarriaga,Eshetu G. Atenafu,Ahmad Mousa,Carley Langleben,Lynn Anson‐Cartwright,Michael A.S. Jewett,Robert J. Hamilton
出处
期刊:European Urology Oncology [Elsevier BV]
卷期号:7 (5): 1034-1041 被引量:12
标识
DOI:10.1016/j.euo.2024.01.006
摘要

Background Open retroperitoneal lymph node dissection (O-RPLND) is the accepted standard surgical approach to treat retroperitoneal nodal disease in testis cancer. Increasingly, robotic RPLND (R-RPLND) is being performed due to the potential for lower blood loss, shorter length of stay, and accelerated recovery. Objective We have performed a propensity score matching (PSM) analysis comparing the survival and perioperative outcomes of O- and R-RPLND. Design, setting, and participants Analyzing the data from all patients who underwent primary RPLND at our center between 1990 and 2022, we used PSM to create a 2:1 (O-RPLND:R-RPLND) matched cohort. Intervention Primary O-RPLND versus R-RPLND. Outcome measurements and statistical analysis The primary endpoint was time to relapse. The secondary endpoints included operating time, length of stay, estimated blood loss (EBL), and surgical complications. Relapse-free survival rates were calculated using the Kaplan-Meier method, and log-rank tests were used to compare perioperative outcomes of O-RPLND versus R-RPLND. Key findings and limitations A total of 178 patients underwent primary RPLND: 137 O-RPLND and 41 R-RPLND. After PSM, 26 patients in the R-RPLND group were matched with 38 in the O-RPLND group. After matching, no significant baseline differences were noted. After a median follow-up of 23.5 mo (interquartile range 4.4–59.2), one (3.8%) relapse was noted in the R-RPLND group versus three (7.8%) in the O-RPLND group; however, this was not significant (hazard ratio 0.65, 95% confidence interval 0.07–6.31, p = 0.7097). No in-field relapses occurred in either cohort. R-RPLND was associated with a shorter length of stay (1 vs 5 d, p < 0.0001) and lower EBL (200 vs 300 ml, p = 0.032), but longer operative time (8.8 vs 4.3 h, p < 0.0001). Conclusions R-RPLND offers low morbidity and improved perioperative outcomes, while maintaining oncologic efficacy of the open approach. Patient summary To the best of our knowledge, this is the first study to compare open and robotic retroperitoneal lymph node dissection (R-RPLND) using a propensity score–matched system. We encourage the discussion and inclusion of primary R-RPLND into the standard of care algorithm for patients with de novo clinical stage (CS) II and relapsed CS I with CS II equivalent disease.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
xyz完成签到,获得积分20
1秒前
Hello的应助被木子采纳,获得10
1秒前
骑猪的飞行员完成签到,获得积分10
1秒前
1秒前
G.Huang发布了新的文献求助30
2秒前
稳重的依风完成签到,获得积分10
2秒前
水煮电吹风的应助被zzz采纳,获得10
2秒前
2秒前
3秒前
一颗发芽的枯木完成签到,获得积分10
3秒前
852的应助被woy031222采纳,获得10
3秒前
王文艺发布了新的文献求助10
4秒前
康子浩发布了新的文献求助10
5秒前
DW的应助被山山而川采纳,获得10
5秒前
纯情的阁的应助被mmmm采纳,获得310
6秒前
DS完成签到,获得积分10
6秒前
干雅柏完成签到,获得积分10
7秒前
无极微光的应助被yon采纳,获得20
7秒前
7秒前
NIKO发布了新的文献求助10
7秒前
wang完成签到 ,获得积分10
7秒前
8秒前
orixero的应助被暮离采纳,获得10
8秒前
司空蓝完成签到,获得积分10
8秒前
8秒前
沙沙完成签到,获得积分10
9秒前
WW发布了新的文献求助20
9秒前
cdercder的应助被kklove采纳,获得10
9秒前
干雅柏发布了新的文献求助10
9秒前
9秒前
胡图图完成签到,获得积分10
9秒前
充电宝的应助被科研通管家采纳,获得10
10秒前
10秒前
丘比特的应助被科研通管家采纳,获得10
10秒前
天天快乐的应助被科研通管家采纳,获得10
10秒前
英俊的铭的应助被yksii采纳,获得10
10秒前
10秒前
jzt12138发布了新的文献求助10
10秒前
所所的应助被科研通管家采纳,获得10
10秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
What Else Can I Tell You?: A Pragmatic Study of English Rhetorical Questions as Discursive and Argumentative Acts 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8163664
求助须知:如何正确求助?哪些是违规求助? 9557817
关于积分的说明 21741980
捐赠科研通 7754358
什么是DOI,文献DOI怎么找? 3428338
关于科研通互助平台的介绍 2553000
邀请新用户注册赠送积分活动 2472943